Analysis of post-market adverse events of tafamidis base on the FDA adverse event reporting system
Nature Research » Drug Safety
by
2d ago
..read more
Visit website
A systematic review and meta-analysis, investigating dose and time of fluvoxamine treatment efficacy for COVID-19 clinical deterioration, death, and Long-COVID complications
Nature Research » Drug Safety
by
2d ago
..read more
Visit website
Efficacy and safety of antithrombotic therapy for preventing and treating pediatric thromboembolic disease: a systematic review
Nature Research » Drug Safety
by
2d ago
..read more
Visit website
Author Correction: Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer
Nature Research » Drug Safety
by
1w ago
..read more
Visit website
Identification of cross reactive T cell responses in adenovirus based COVID 19 vaccines
Nature Research » Drug Safety
by
1w ago
..read more
Visit website
Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population
Nature Research » Drug Safety
by
2w ago
..read more
Visit website
Introduction of sugar-modified nucleotides into CpG-containing antisense oligonucleotides inhibits TLR9 activation
Nature Research » Drug Safety
by
2w ago
..read more
Visit website
A real-world pharmacovigilance study of FDA adverse event reporting system events for Capmatinib
Nature Research » Drug Safety
by
2w ago
..read more
Visit website
P75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial
Nature Research » Drug Safety
by
2w ago
..read more
Visit website
Data mining and safety analysis of avatrombopag: a retrospective pharmacovigilance study based on the US food and drug administration’s adverse event reporting system
Nature Research » Drug Safety
by
2w ago
..read more
Visit website

Follow Nature Research » Drug Safety on FeedSpot

Continue with Google
Continue with Apple
OR